A randomized, open-label study comparing the anti-tumor effect of treatment with Tarceva plus Avastin versus chemotherapy plus Avastin in patients with advanced non-small cell lung cancer
Phase of Trial: Phase II
Latest Information Update: 10 Dec 2014
At a glance
- Drugs Bevacizumab (Primary) ; Erlotinib (Primary) ; Antineoplastics; Platinum complexes
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Roche
- 31 Aug 2018 Biomarkers information updated
- 29 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 Oct 2011 Planned end date changed from 1 Sep 2011 to 1 Oct 2011 as reported by ClinicalTrials.gov.